| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b86e50a7529f6158517db14a0b81df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b98485d9767bb194d0bf74229abac1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1b33e97820355d77a6d5689e1ca194d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1df8e1a5de93a8815f7a5d8e023ec2d8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6421 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-6852 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-00 |
| filingDate |
2012-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e59bae4c0542cc79f7ad0d2d2f136eeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f1f0c360d2fe9ad2b89740878b3d9f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd4265947909d666b193d448301983f0 |
| publicationDate |
2016-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9498136-B2 |
| titleOfInvention |
Classification of tumor tissue with a personalized threshold |
| abstract |
The present invention deals with discrimination of malignant tissue from normal and benign tissue in a single patient on the basis of optical spectroscopic measurements. Starting from spectroscopic measurements in normal tissue, reference values are obtained for the normal class. With spectroscopic measurements in other tissues data points can be assigned to new class(es) when the spectral characteristics fall outside a threshold defining the reference class. Thresholds between different classes can also be defined. Finding (the transition to) malignant tissue is based on comparing the spectroscopic values to the classification threshold discriminating normal and benign versus malignant tissue. Thus, the basis of normal spectroscopic measurements is tuned to the individual patient characteristic. Discriminating the normal plus benign and malignant from that reference is more efficient compared to the reference of the all patient database. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021161387-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017209049-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10912462-B2 |
| priorityDate |
2011-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |